wiis/wiːs/Write It, I'll Share

Fair-Value Report — Seres Group Co., Ltd. - H Shares (9927.HK)

by hkse-stock-research

赛力斯集团股份有限公司 · A+H dual-listed · A-shares 601127.SS (Shanghai)
Speculative Buy Price HK$32.86 (2026-09-28) FV (H) ≈ HK$38–39 Upside ≈ +17% Signal: small, genuine

Insider signal

Buyer: Chongqing Xiaokang Holding Co., Ltd. (重慶小康控股有限公司) and concert parties — the controlling-shareholder vehicle of chairman/actual controller Zhang Xinghai (張兴海), who personally owns 50% of the holding company. This is the company's founder and largest shareholder, not a nominee or fund.

What happened: On 2026-09-22 the holding company bought 1,000,000 H-shares of 9927.HK on-market at an average price of HK$35.1343 (≈HK$35.13M), taking its H-share long position from 0.00% to a disclosable threshold. A further tranche reported through 2026-09-24 brought the cumulative H-share stake to 0.92% on cumulative consideration of ≈HK$39.79M. Reason code 1101 (on-exchange purchase) — genuine open-market accumulation, not a placing, pledge, or scheme.

Same program, A-share leg: Over a wider window, 2026-07-15 to 2026-09-24, the same controlling shareholder and its concert parties bought 4.1501M A-shares on the Shanghai exchange via centralized bidding, lifting the combined stake from 26.79% to 27.03%. The H-share buy is a small, opportunistic extension of that same ongoing program — executed via the cheaper H-share tranche (see A-H discount below).

Timing/catalyst: The buying coincided with an announced restructuring of the Huawei/HIMA (鸿蒙智行) cooperation model — Seres taking direct control of AITO product definition, design, branding, retail channel and after-sales service, with Huawei's terminal unit stepping back into an "enablement" role rather than co-managing the brand. This is a genuine strategic inflection for the company, not routine housekeeping.

Honest caveat on signal strength: in absolute terms the H-share purchase is small (≈HK$35–40M against a ~HK$91B combined-class market cap) — a symbolic/opportunistic top-up alongside a much larger A-share program, not a large fresh commitment of capital. Treat it as confirmatory, not as the primary reason to own the stock.

Verified snapshot

H-share price
HK$32.86
9927.HK, close 2026-09-28 (also 32.54 on 9/25, 32.86 on 9/27 — converging across sources)
A-share price
CNY 44.87
601127.SS, 2026-09-28
Combined market cap
≈HK$91.5B
≈CNY78.2B; total shares × A-share price (dominant listing convention)
Total shares
1.742B
A: 1,633,366,086 + H: 108,619,000 (as of 2026-01-31 filing)
52-wk range (H)
32.22–131.50
down ~70%+ since Nov-2025 HKEX listing
A-H discount
≈37%
HK$32.86 vs A-equivalent ≈HK$52.50 (CNY44.87 × 1.17 FX)

Business

Seres (formerly Sokon/Xiaokang Group, founded 1986) is a China-based NEV manufacturer, best known for the AITO brand of premium SUVs (M5/M6/M7/M8/M9) co-developed with Huawei under the HarmonyOS Intelligent Mobility Alliance (HIMA/鸿蒙智行). FY2025 was a record year: revenue CNY165.05B (+13.7% YoY), net profit CNY5.96B (+0.2% YoY), full-year NEV sales ~1.1M+ units led by the M9 (#1 in the CNY500k+ SUV segment). The AITO relationship has historically been the core value driver — Huawei supplies ADAS/cockpit software and co-manages branding/retail, Seres manufactures.

2026 has been materially rougher: H1 2026 revenue CNY57.49B (-7.9% YoY) with a swing to a net loss of CNY1.72B (vs +CNY2.94B in H1 2025), management citing (a) rising input costs — memory chips, industrial metals, lithium carbonate, and (b) a book-value write-down on model-specific tooling/inventory tied to the M-series generational transition. Q1 2026 alone was still profitable (CNY754M), so the loss is concentrated in Q2 2026 — consistent with a chunky, partly one-off impairment rather than a pure cash operating bleed. Monthly deliveries have deteriorated sharply and faster than the P&L shows: August 2026 NEV sales were 24,000 units (-44.0% YoY; AITO -49.7% YoY), cumulative Jan–Aug -12.6% YoY. Trailing-twelve-month (TTM) revenue is still growing (+12.4% YoY to ≈CNY160B / HK$187B) and TTM net income remains marginally positive (≈CNY1.3–1.5B, margin <1%, down ~80% YoY) — but the TTM figures lag the much worse real-time trend, and H2 2026 results (due ~Q1 2027) are the key thing to watch.

Balance sheet: cash reserves of CNY73.15B at H1 2026 (company states the balance-sheet structure remains "robust"); book value per share CNY17.02 (total equity ≈CNY29.65B), implying FY2025 ROE of ~20% — strong by auto-sector standards, though 2026 will compress it. Precise interest-bearing debt was not separately disclosed in the sources reviewed; net debt is treated as modestly net-cash below and flagged as an estimate.

Valuation — three-scenario DCF (RMB)

Classified as a profitable operating company in a volatile transition (not pre-commercial, not a shell) — TTM profitable with a real, scaled, cash-generative business, but near-term visibility is unusually poor given the Huawei-relationship reset and the accelerating volume decline. Scenario weights are skewed away from the 25/50/25 default to 20% bull / 40% base / 40% bear to reflect that binary-catalyst uncertainty. WACC built bottom-up: China 10Y risk-free 1.6%, Damodaran auto-industry beta 1.24 unlevered (relevered ≈1.25 given Seres' low leverage), mature-market ERP 4.17% + China country risk premium 1.01% (total ERP 5.18%), pre-tax cost of debt 3.8%, 15% PRC high-tech-enterprise tax rate, 8% target debt weight → WACC 7.46%.

ScenarioWeightNarrativeFV/share (CNY)
Bull20%M9 Ultimate + M6/M7 refresh restore volume growth; post-restructuring economics improve as Seres captures more of the value chain; op. margin recovers to 8%129.26
Base40%Volumes stabilize after 1–2 more soft quarters; op. margin normalizes to ~5% (below 2025 peak); modest low-single-digit long-run growth56.28
Bear40%Huawei-channel disruption persists, further share loss to Xiaomi/Li Auto/domestic rivals; margins stay near breakeven for years10.47
Probability-weighted FV100%—52.55

Against the A-share price (CNY44.87, same currency as the model), the probability-weighted DCF implies ≈+17% upside. Converting to HKD at spot FX (1 CNY ≈ 1.17 HKD) gives an intrinsic-equivalent value of ≈HK$61.5 — but the H-share tranche has traded at a persistent ~37% structural discount to the A-share (small free float, only listed since Nov-2025, different investor base, capital-account segmentation typical of A+H pairs). Absent a specific catalyst to close that gap, the more realistic H-share fair value applies the same proportional upside to the current H-share price rather than assuming full A-H convergence: ≈HK$38–39, i.e. also ≈+17% upside from HK$32.86. Full convergence of the A-H discount (not the base case here) would be a separate, unquantified source of additional upside optionality for H-share holders specifically.

Reverse DCF — what the price implies

Solve forImplied valueRead
Flat 10-yr revenue growth (at base-case margins)-0.95%/yrMarket is pricing in mild, multi-year stagnation — not a recovery, but also not the full bear-case collapse
Flat operating margin (at base-case growth path)3.58%Below the FY2025 realized margin (~4.5–5% estimated), consistent with the market already discounting a permanently thinner-margin business

This is a useful sanity check: the market isn't irrationally pessimistic (it isn't pricing outright decline into perpetuity), but it also isn't giving Seres credit for any recovery in the Huawei-transition thesis. A DCF fair value modestly above the current price is therefore a reasonable, non-aggressive conclusion.

Peer relative valuation

Peer set: major HK-listed Chinese NEV/auto makers, all data same-source (stockanalysis.com) and same-day (2026-09-28) for comparability. EV ≈ market cap for all names (net-cash balance sheets).

TickerMkt Cap (HK$)Rev TTM (HK$)EV/RevP/E (ttm)Rev gr% (ttm)Net margin
9927 Seres (target)91.5B187.4B0.49x~61x+12.4%+0.8%
2015 Li Auto88.5B121.0B0.73xn/a (loss)-26.9%-4.4%
9868 XPeng76.0B87.1B0.87xn/a (loss)+25.1%-4.1%
9866 NIO70.3B154.1B0.46xn/a (loss)+64.4%-4.2%
1211 BYD820.0B897.6B0.91x21.0x-8.2%+3.8%
Median (ex-target)——0.80x21.0x-1.6%-4.2%

Seres trades at a ≈39% discount to peer median EV/Revenue (0.49x vs 0.80x). That discount is only partly justified by fundamentals: Seres' TTM revenue growth (+12.4%) beats two of four peers, and it is one of only two names in the set (with BYD) that is TTM net-income positive — yet it prices cheaper than all of them bar NIO. The residual gap is best explained by (a) the accelerating real-time volume collapse not yet visible in TTM figures, (b) H-share-specific illiquidity/A-H discount, and (c) genuine uncertainty about post-Huawei-restructuring economics. Not a screaming statistical anomaly, but a name priced for continued deterioration that the TTM numbers don't yet fully show.

Conclusion — Speculative Buy

The insider signal is real (founder/chairman-controlled entity, genuine on-market purchase, tied to a substantive strategic catalyst) but small and largely symbolic in isolation — its main value here is confirmatory, riding alongside a bigger A-share buying program. The valuation case stands on its own: DCF and peer-relative both point to modest (~15–20%) undervaluation even under a scenario mix skewed 40% to a bear case, the reverse DCF shows the market is not pricing in a rosy outcome, and the balance sheet (net cash, ~20% FY2025 ROE) provides real downside cushion. The offsetting risk — an accelerating, not-yet-fully-reported volume collapse (August deliveries down ~44% YoY) — is serious enough to keep this speculative rather than a straight Buy: H2 2026 results and September/October delivery data will be the first hard evidence of whether the Huawei-transition thesis is working or whether the brand is losing structural share.

Key risks

Sources

HKEX Disclosure of Interests filings (via Futu/新浪 news summaries citing the DI form, 2026-09-22/24); Seres Group 2025 Annual Report (cninfo.com.cn, filed 2026-03-31); Seres H1 2026 results announcement and earnings-warning filing (2026-07-12/13, 2026-08-19, via 新浪财经/IT之家/东方财富); monthly production-and-sales bulletins (2026-09-02, via 新浪科技/腾讯新闻); share-capital structure filing as of 2026-01-31 (via 同花顺/新浪财经); stockanalysis.com (price/market cap/peer financials, 9927.HK, 601127.SS, 2015.HK, 9868.HK, 9866.HK, 1211.HK — all pulled 2026-09-28); investing.com (601127.SS price cross-check, 2026-09-28); Damodaran NYU Stern data (industry beta, country ERP, July 2026 update); China 10Y government bond yield (tradingeconomics/MacroMicro, Sept 2026).

Not investment advice. This report reflects publicly available information as of the dates cited and may be incomplete or become outdated. The author holds no position in 9927.HK, 601127.SS, or any peer named above. Figures denominated in CNY and HKD as noted; FX conversions use an approximate spot rate of 1 CNY ≈ 1.17 HKD (Sept 2026) and are illustrative, not tradeable quotes.

Discussion

No comments yet.

No redactions applied.

Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.